telbivudine has been researched along with transforming growth factor beta in 2 studies
| Studies (telbivudine) | Trials (telbivudine) | Recent Studies (post-2010) (telbivudine) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 486 | 85 | 332 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Li, D | 1 |
| Chen, J; Li, D; Luo, E | 1 |
2 other study(ies) available for telbivudine and transforming growth factor beta
| Article | Year |
|---|---|
Telbivudine attenuates UUO-induced renal fibrosis via TGF-β/Smad and NF-κB signaling.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Fibrosis; Hepatitis B virus; Humans; Inflammation Mediators; Kidney; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Telbivudine; Thymidine; Transforming Growth Factor beta; Ureter; Ureteral Obstruction | 2018 |
Telbivudine antagonizes TLR4 to inhibit the epithelial-to-mesenchymal transition in human proximal tubular epithelial cells in vitro.
Topics: Antiviral Agents; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Immunity, Innate; Kidney Tubules, Proximal; Lipopolysaccharides; Renal Insufficiency, Chronic; Signal Transduction; Smad Proteins; Telbivudine; Toll-Like Receptor 4; Transforming Growth Factor beta | 2019 |